Suppr超能文献

为造血祖细胞移植患者实施基于证据的营养支持路径。

Implementation of an evidenced based nutrition support pathway for haematopoietic progenitor cell transplant patients.

作者信息

Andersen Sarah, Brown Teresa, Kennedy Glen, Banks Merrilyn

机构信息

Department of Nutrition and Dietetics, Royal Brisbane and Women's Hospital, Herston, QLD 4029, Australia.

Department of Nutrition and Dietetics, Royal Brisbane and Women's Hospital, Herston, QLD 4029, Australia.

出版信息

Clin Nutr. 2015 Jun;34(3):536-40. doi: 10.1016/j.clnu.2014.06.006. Epub 2014 Jun 17.

Abstract

BACKGROUND AND AIMS

The type of nutrition support given during haematopoietic progenitor cell transplantation (HPCT) varies greatly between transplant units and often includes enteral nutrition (EN) and/or parenteral nutrition (PN). The aims of this study were to develop an evidenced based nutrition support pathway for HPCT patients and then evaluate changes in nutrition support practices post implementation of the pathway into clinical practice.

METHODS

A retrospective audit of 66 consecutive patients who underwent HPCT during the six months prior to the development of the pathway was undertaken, followed by a prospective audit of 61 consecutive patients undertaking HPCT during the six months post implementation. Data collected included type and timing of nutrition support given.

RESULTS

Post implementation of the pathway the use of PN for allogeneic HPCT patients reduced significantly from 86% to 50% (p < 0.001) and use of oral nutrition support increased significantly from 14% to 45% (p = 0.003). Autologous HPCT recipients had shorter lengths of inadequate intake with only 30% of patients having a poor intake for greater than one week compared to 72% prior to implementation of the pathway (p = 0.02).

CONCLUSION

Implementation of a nutrition support pathway impacts significantly on appropriate use of nutritional support in recipients of HPCT.

摘要

背景与目的

造血祖细胞移植(HPCT)期间给予的营养支持类型在各移植单位之间差异很大,通常包括肠内营养(EN)和/或肠外营养(PN)。本研究的目的是为HPCT患者制定基于证据的营养支持路径,然后评估该路径在临床实践中实施后营养支持实践的变化。

方法

对路径制定前六个月内连续66例接受HPCT的患者进行回顾性审计,随后对路径实施后六个月内连续61例接受HPCT的患者进行前瞻性审计。收集的数据包括给予营养支持的类型和时间。

结果

路径实施后,异基因HPCT患者的PN使用从86%显著降至50%(p<0.001),口服营养支持的使用从14%显著增加至45%(p=0.003)。自体HPCT受者摄入不足的时间缩短,只有30%的患者摄入不良超过一周,而在路径实施前这一比例为72%(p=0.02)。

结论

营养支持路径的实施对HPCT受者营养支持的合理使用有显著影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验